title: Disseminated growth of Hodgkin's-derived cell lines L540 and L540cy in immune-deficient SCID mice.
abstract: Local tumor growth has been reported after subcutaneous and intraperitoneal injection of Hodgkin's disease (HD) derived cell lines into different immunodeficient mouse strains. An animal model with disseminated growth of tumor cells would be useful for studying the in vivo biology of HD cells as well as for preclinical testing of new therapeutic regimens. For this purpose the HD-derived cell lines L540, L540cy, L428, and KM-H2 were injected intravenously into SCID mice. In contrast to L428 and KM-H2, widespread neoplasia occurred after a period of four to six weeks following injection of L540 and the subline L540cy. Lymph nodes were found to be the preferred site of tumor growth. CD30 surface antigen expression on Hodgkin cells and the karyotype of the tumor cells were preserved in the animal host. Thus, to a large extent, the SCID mouse model mimics the dissemination pattern of Hodgkin's disease in man. To evaluate the role of adhesion molecule expression in the dissemination of HD-derived cell lines, CD44 and members of the immunoglobulin, integrin, selectin, and Fc receptor families were quantified by flow cytometry. CD30 expression was also measured. Although CD44 expression has been correlated with dissemination in non-Hodgkin's lymphoma (NHL), this was not the case in the Hodgkin's SCID mouse model. CD44 was not expressed on the disseminating cell lines L540 and L540cy but was expressed in the nondisseminating lines L428 and KM-H2.
authors.affiliation: Klinik I für Innere Medizin and Institut für Medizinische Dokumentation und Statistik, University of Cologne, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Kapp
authors.forename: A
authors.initials: A
authors.lastname: Düx
authors.forename: E
authors.initials: E
authors.lastname: Schell-Frederick
authors.forename: N
authors.initials: N
authors.lastname: Banik
authors.forename: M
authors.initials: M
authors.lastname: Hummel
authors.forename: S
authors.initials: S
authors.lastname: Mücke
authors.forename: C
authors.initials: C
authors.lastname: Fonatsch
authors.forename: J
authors.initials: J
authors.lastname: Bullerdiek
authors.forename: C
authors.initials: C
authors.lastname: Gottstein
authors.forename: A
authors.initials: A
authors.lastname: Engert
mesh_terms: D000818:Animals; D002352:Carrier Proteins / Q000097:blood; D015815:Cell Adhesion Molecules / Q000502:physiology*; D005434:Flow Cytometry; D006689:Hodgkin Disease / Q000276:immunology / Q000473:pathology*; D018960:Hyaluronan Receptors; D007136:Immunoglobulins / Q000032:analysis; D007275:Injections, Intravenous; D016023:Integrins / Q000032:analysis; D007621:Karyotyping; D017730:Ki-1 Antigen / Q000097:blood; D051379:Mice; D016513:Mice, SCID; D011956:Receptors, Cell Surface / Q000032:analysis; D011961:Receptors, Fc / Q000032:analysis; D016201:Receptors, Lymphocyte Homing / Q000032:analysis; D016511:Severe Combined Immunodeficiency / Q000473:pathology*; D014407:Tumor Cells, Cultured
chemical_list: D002352:Carrier Proteins; D015815:Cell Adhesion Molecules; D018960:Hyaluronan Receptors; D007136:Immunoglobulins; D016023:Integrins; D017730:Ki-1 Antigen; D011956:Receptors, Cell Surface; D011961:Receptors, Fc; D016201:Receptors, Lymphocyte Homing